The loan transaction, completed in March, was used to fund a dividend made payable to its stock holders.
Bausch + Lomb is currently $3.3 billion in debt.
More Articles on Ophthalmology:
Dr. Gholma Peyman Joins Insite Vision
5 Recent Ophthalmology-Driven Facility Openings & Expansions
Dr. Balamurali Ambati Leads Study of Nanoparticles as Maculr Degeneration Treatment
